Work

Small Molecule Allosteric Inhibitor of HIPK2 as a Novel Therapy against Kidney Fibrosis

Year: 2024
Type: article
Abstract: 1Icahn School of Medicine at Mount Sinai, New York, New York 2Rila Therapeutics Inc, South San Francisco, California 3ShangPharma Innovations Inc, South San Francisco, California Correspondence: Dr. John C. He or Dr. Kyung Lee, email: [email protected] or [email protected]
Language: English
Subfield: Nephrology
Field: Medicine
Open Access status: green
OpenAlex ID: W4392749504
FWCI: 3.262
Cites: 9
Cited by: 13
Related to: 10